Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy.

Gupta, Arjun; Harris, Samar; Vernino, Steven; Naina, Harris V

Gupta, Arjun; Harris, Samar; Vernino, Steven; Naina, Harris V.

Affiliation

Gupta A; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. guptaarjun90@gmail.com.
Harris S; Department of Gastroenterology and Hepatology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Vernino S; Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Naina HV; Department of Hematology, University of Texas Southwestern Medical Center, Seay Biomedical Building, 2201 Inwood Road, Dallas, TX, 75390-8562, USA. Harris.Naina@UTSouthwestern.edu.

Clin Auton Res ; 25(4): 255-8, 2015 Aug.

Article de En | MEDLINE | ID: mdl-26245264

ABSTRACT

ABSTRACT

We present a patient with autoimmune autonomic ganglionopathy (AAG) who had persistently positive ganglionic nicotinic acetylcholine receptor antibody levels despite immunosuppressive therapy. Rituximab-based therapy for an incidental lymphoma was associated with prolonged symptomatic and serological control of AAG.

Sujet(s)
Mots clés

Autoimmune autonomic ganglionopathy; Management; Rituximab

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies auto-immunes du système nerveux / Rituximab / Ganglions du système nerveux autonome / Facteurs immunologiques Limites: Humans / Male / Middle aged Langue: En Journal: Clin Auton Res Sujet du journal: NEUROLOGIA Année: 2015 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google